Concepts (80)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
| Critical Pathways | 1 | 2021 | 1587 | 0.42 | Why? |
| Guideline Adherence | 1 | 2021 | 2309 | 0.34 | Why? |
| Antibodies, Monoclonal, Humanized | 2 | 2020 | 9335 | 0.23 | Why? |
| Anti-Inflammatory Agents | 1 | 2020 | 6153 | 0.22 | Why? |
| Medical Audit | 1 | 2021 | 218 | 0.20 | Why? |
| Mediastinal Neoplasms | 1 | 2020 | 57 | 0.20 | Why? |
| Ireland | 2 | 2020 | 1456 | 0.18 | Why? |
| Hodgkin Disease | 1 | 2020 | 204 | 0.17 | Why? |
| Clinical Trials, Phase II as Topic | 1 | 2020 | 801 | 0.17 | Why? |
| Bone Diseases, Metabolic | 1 | 2017 | 64 | 0.16 | Why? |
| Multicenter Studies as Topic | 2 | 2020 | 2437 | 0.16 | Why? |
| Practice Guidelines as Topic | 1 | 2021 | 15421 | 0.16 | Why? |
| Positron-Emission Tomography | 1 | 2020 | 802 | 0.14 | Why? |
| False Negative Reactions | 1 | 2021 | 1785 | 0.13 | Why? |
| Tomography, X-Ray Computed | 1 | 2021 | 25144 | 0.13 | Why? |
| Bone Density | 1 | 2017 | 335 | 0.13 | Why? |
| Lung | 1 | 2021 | 31049 | 0.11 | Why? |
| Blood Platelets | 1 | 2021 | 1704 | 0.10 | Why? |
| World Health Organization | 1 | 2021 | 4213 | 0.09 | Why? |
| Cardiopulmonary Resuscitation | 1 | 2021 | 1876 | 0.09 | Why? |
| Patient Care Team | 1 | 2021 | 3556 | 0.08 | Why? |
| Hydroxychloroquine | 2 | 2020 | 12447 | 0.08 | Why? |
| Azithromycin | 1 | 2020 | 3943 | 0.07 | Why? |
| Disease Progression | 2 | 2020 | 13580 | 0.07 | Why? |
| Intubation, Intratracheal | 1 | 2020 | 3962 | 0.07 | Why? |
| Randomized Controlled Trials as Topic | 2 | 2020 | 10649 | 0.07 | Why? |
| Betacoronavirus | 4 | 2020 | 204454 | 0.07 | Why? |
| Thrombopoietin | 1 | 2021 | 52 | 0.06 | Why? |
| Idarubicin | 1 | 2020 | 15 | 0.05 | Why? |
| Procarbazine | 1 | 2020 | 14 | 0.05 | Why? |
| Vinblastine | 1 | 2020 | 48 | 0.05 | Why? |
| Dacarbazine | 1 | 2020 | 67 | 0.05 | Why? |
| Vincristine | 1 | 2020 | 89 | 0.05 | Why? |
| Cytarabine | 1 | 2020 | 64 | 0.05 | Why? |
| Time Factors | 2 | 2020 | 31397 | 0.05 | Why? |
| Platelet Function Tests | 1 | 2021 | 231 | 0.05 | Why? |
| Resuscitation Orders | 1 | 2021 | 188 | 0.05 | Why? |
| Etoposide | 1 | 2020 | 115 | 0.05 | Why? |
| P-Selectin | 1 | 2021 | 224 | 0.05 | Why? |
| Bleomycin | 1 | 2020 | 195 | 0.05 | Why? |
| Mean Platelet Volume | 1 | 2021 | 203 | 0.05 | Why? |
| Treatment Outcome | 3 | 2020 | 51732 | 0.05 | Why? |
| Adenosine Triphosphate | 1 | 2021 | 294 | 0.05 | Why? |
| Cyclophosphamide | 1 | 2020 | 387 | 0.04 | Why? |
| Pneumonia, Viral | 4 | 2020 | 243684 | 0.04 | Why? |
| Documentation | 1 | 2021 | 332 | 0.04 | Why? |
| Anti-Bacterial Agents | 1 | 2020 | 10083 | 0.04 | Why? |
| Coronavirus Infections | 4 | 2020 | 253789 | 0.04 | Why? |
| Doxorubicin | 1 | 2020 | 313 | 0.04 | Why? |
| Platelet Factor 4 | 1 | 2021 | 385 | 0.04 | Why? |
| Absorptiometry, Photon | 1 | 2017 | 168 | 0.04 | Why? |
| Prednisone | 1 | 2020 | 652 | 0.04 | Why? |
| Respiration, Artificial | 1 | 2020 | 22116 | 0.04 | Why? |
| Hemostasis | 1 | 2021 | 811 | 0.03 | Why? |
| Drug Administration Schedule | 1 | 2020 | 2324 | 0.03 | Why? |
| Retrospective Studies | 2 | 2021 | 105322 | 0.03 | Why? |
| Severity of Illness Index | 1 | 2020 | 48226 | 0.03 | Why? |
| Aged | 4 | 2021 | 215776 | 0.03 | Why? |
| HIV Infections | 1 | 2017 | 11620 | 0.03 | Why? |
| Aged, 80 and over | 1 | 2021 | 88759 | 0.03 | Why? |
| Humans | 8 | 2021 | 930598 | 0.03 | Why? |
| Young Adult | 1 | 2021 | 93724 | 0.02 | Why? |
| Antineoplastic Combined Chemotherapy Protocols | 1 | 2020 | 1573 | 0.02 | Why? |
| Phenotype | 1 | 2021 | 4037 | 0.02 | Why? |
| Adult | 3 | 2021 | 244371 | 0.02 | Why? |
| Blood Coagulation | 1 | 2021 | 2768 | 0.02 | Why? |
| Middle Aged | 3 | 2021 | 270681 | 0.02 | Why? |
| Female | 4 | 2021 | 380317 | 0.02 | Why? |
| Pandemics | 5 | 2021 | 389249 | 0.02 | Why? |
| Antiviral Agents | 1 | 2020 | 41703 | 0.02 | Why? |
| Decision Making | 1 | 2021 | 3132 | 0.02 | Why? |
| Oxygen | 1 | 2020 | 3715 | 0.02 | Why? |
| Health Status | 1 | 2020 | 3259 | 0.02 | Why? |
| Enzyme-Linked Immunosorbent Assay | 1 | 2021 | 7868 | 0.02 | Why? |
| Male | 3 | 2021 | 367725 | 0.02 | Why? |
| Prospective Studies | 2 | 2020 | 43301 | 0.02 | Why? |
| Longitudinal Studies | 1 | 2017 | 9893 | 0.01 | Why? |
| Inflammation | 1 | 2021 | 13255 | 0.01 | Why? |
| Intensive Care Units | 1 | 2021 | 29594 | 0.01 | Why? |
| Cross-Sectional Studies | 1 | 2021 | 53120 | 0.01 | Why? |
Cotter's Networks
Click the
Explore
buttons for more information and interactive visualizations!
Concepts
(80)
Derived automatically from this person's publications.
Explore
_
Co-Authors
(84)
People in Profiles who have published with this person.
Explore
_
Similar People
(60)
People who share similar concepts with this person.
Explore
_